CA2367412A1 - Compositions et methodes de traitement et de diagnostic du cancer de la prostate - Google Patents

Compositions et methodes de traitement et de diagnostic du cancer de la prostate Download PDF

Info

Publication number
CA2367412A1
CA2367412A1 CA002367412A CA2367412A CA2367412A1 CA 2367412 A1 CA2367412 A1 CA 2367412A1 CA 002367412 A CA002367412 A CA 002367412A CA 2367412 A CA2367412 A CA 2367412A CA 2367412 A1 CA2367412 A1 CA 2367412A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
cells
sequence
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002367412A
Other languages
English (en)
Inventor
Carlota Vinals Y De Bassols
Jennifer Irmela Klee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2367412A1 publication Critical patent/CA2367412A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions polypeptidiques, des compositions polynucléotidiques, des compositions d'anticorps et analogues, destinées au traitement du cancer de la prostate, ainsi que des méthodes de préparation de ces compositions. L'invention concerne également des méthodes d'utilisation de ces compositions dans diverses applications diagnostiques, prophylactiques et/ou thérapeutiques.
CA002367412A 1999-04-07 2000-04-06 Compositions et methodes de traitement et de diagnostic du cancer de la prostate Abandoned CA2367412A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9907860.2A GB9907860D0 (en) 1999-04-07 1999-04-07 Novel compounds
GB9907860.2 1999-04-07
PCT/US2000/009450 WO2000060084A1 (fr) 1999-04-07 2000-04-06 Compositions et methodes de traitement et de diagnostic du cancer de la prostate

Publications (1)

Publication Number Publication Date
CA2367412A1 true CA2367412A1 (fr) 2000-10-12

Family

ID=10851034

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002367412A Abandoned CA2367412A1 (fr) 1999-04-07 2000-04-06 Compositions et methodes de traitement et de diagnostic du cancer de la prostate

Country Status (5)

Country Link
EP (1) EP1169450A1 (fr)
AU (1) AU4452900A (fr)
CA (1) CA2367412A1 (fr)
GB (1) GB9907860D0 (fr)
WO (1) WO2000060084A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146382A0 (en) 1999-05-13 2002-07-25 American Cyanamid Co Adjuvant combination formulations
WO2002022783A2 (fr) * 2000-09-15 2002-03-21 Digital Gene Technologies, Inc. Expression genique du foie associee a l'inhibition de la replication ou de la transcription de hbv
US20030031678A1 (en) * 2000-09-19 2003-02-13 Shujath Ali Compositions and methods relating to prostate specific genes and proteins
PL366031A1 (en) * 2000-11-10 2005-01-24 Wyeth Holdings Corporation Adjuvant combination formulations
WO2002044332A2 (fr) * 2000-12-01 2002-06-06 Origene Technologies Inc Polynucleotides de la prostate et utilisations associees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180045T3 (es) * 1996-04-19 2003-02-01 Us Gov Sec Health Peptidos ras mutados para la generacion de linfocitos t citotoxicos cd8+.

Also Published As

Publication number Publication date
GB9907860D0 (en) 1999-06-02
AU4452900A (en) 2000-10-23
EP1169450A1 (fr) 2002-01-09
WO2000060084A1 (fr) 2000-10-12

Similar Documents

Publication Publication Date Title
US6630574B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
JP5053497B2 (ja) 乳癌の治療および診断のための組成物および方法
WO2001040269A2 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
US6844325B2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6746846B1 (en) Methods for diagnosing lung cancer
CA2384499A1 (fr) Sequences de tumeurs ovariennes et procedes d'utilisation correspondants
US20020022591A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US6432707B1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2000078960A2 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
US6667154B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
CA2367412A1 (fr) Compositions et methodes de traitement et de diagnostic du cancer de la prostate
US20020072503A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001070976A2 (fr) Compositions et procedes de therapie et de diagnostic du cancer des ovaires et de l'endometre
WO2002002623A2 (fr) Compositions et methodes de diagnostic et de traitement du cancer des poumons
US6686447B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US6914132B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20020142957A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
US7202342B1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
US20020111308A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20030008299A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001090154A2 (fr) Compositions et procedes therapeutiques et diagnostiques du cancer ovarien
US20020137911A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
KR20020026483A (ko) 폐암의 치료 및 진단을 위한 조성물 및 방법
WO2002012329A2 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer de la tete et du cou
KR20030008369A (ko) 유방암의 치료 및 진단용 조성물 및 방법

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued